Page 1259 - Williams Hematology ( PDFDrive )

1234 Part IX: Lymphocytes and Plasma Cells Chapter 80: Immunodeficiency Diseases 1235

105. Matangkasombut P, Pichavant M, Saez DE, et al: Lack of iNKT cells in patients with 137. Chaigne-Delalande B, Li FY, O’Connor GM, et al: Mg2+ regulates cytotoxic functions
combined immune deficiency due to hypomorphic RAG mutations. Blood 111:271–274, of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341:186–191,
2008. 2013.
106. Markert ML, Alexieff MJ, Li J, et al: Complete DiGeorge syndrome: Development 138. Zhang Q, Davis JC, Lamborn IT, et al: Combined immunodeficiency associated with
of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol DOCK8 mutations. N Engl J Med 361:2046–2055, 2009.
113:734–741, 2004. 139. Engelhardt KR, McGhee S, Winkler S, et al: Large deletions and point mutations involving
107. Gennery AR, Slatter MA, Rice J, et al: Mutations in CHD7 in patients with CHARGE the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE
syndrome cause T-B + natural killer cell + severe combined immune deficiency and syndrome. J Allergy Clin Immunol 124:1289–1302 e4, 2009.
may cause Omenn-like syndrome. Clin Exp Immunol 153:75–80, 2008. 140. Randall KL, Chan SS, Ma CS, et al: DOCK8 deficiency impairs CD8 T cell survival and
108. Torgerson TR, Gambineri E, Ochs HD: Immune dysregulation, polyendocrinopa- function in humans and mice. J Exp Med 208:2305–2320, 2011.
thy, enteropathy, and X-linked inheritance, in Primary Immunodeficiency Diseases, A 141. Mizesko MC, Banerjee PP, Monaco-Shawver L, et al: Defective actin accumulation
Molecular and Genetic Approach, 3rd ed, edited by Ochs HD, Smith CIE, Puck JM, impairs human natural killer cell function in patients with dedicator of cytokinesis 8
pp 395–413. Oxford University Press, New York, 2014. deficiency. J Allergy Clin Immunol 131:840–848, 2013.
109. Fraitag S, Bodemer C: Neonatal erythroderma. Curr Opin Pediatr 22:438–444, 2010. 142. Jabara HH, McDonald DR, Janssen E, et al: DOCK8 functions as an adaptor that links
110. Hauck F, Randriamampita C, Martin E, et al: Primary T-cell immunodeficiency with TLR-MyD88 signaling to B cell activation. Nat Immunol 13:612–620, 2012.
immunodysregulation caused by autosomal recessive LCK deficiency. J Allergy Clin 143. Pai SY, de Boer H, Massaad MJ, et al: Flow cytometry diagnosis of dedicator of cytoki-
Immunol 130:1144–1152 e11, 2012. nesis 8 (DOCK8) deficiency. J Allergy Clin Immunol 134:221–223 e7, 2014.
111. Chan AC, Kadlecek TA, Elder ME, et al: ZAP-70 deficiency in an autosomal recessive 144. Barlogis V, Galambrun C, Chambost H, et al: Successful allogeneic hematopoietic stem
form of severe combined immunodeficiency. Science 264:1599–1601, 1994. cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol 128:420–422 e2,
112. Elder ME, Lin D, Clever J, et al: Human severe combined immunodeficiency due to a 2011.
defect in ZAP-70, a T cell tyrosine kinase. Science 264:1596–1599, 1994. 145. Keles S, Jabara HH, Reisli I, et al: Plasmacytoid dendritic cell depletion in DOCK8
113. Crequer A, Troeger A, Patin E, et al: Human RHOH deficiency causes T cell defects and deficiency: Rescue of severe herpetic infections with IFN-alpha 2b therapy. J Allergy
susceptibility to EV-HPV infections. J Clin Invest 122:3239–3247, 2012. Clin Immunol 133:1753–1755 e3, 2014.
114. Nehme NT, Pachlopnik Schmid J, Debeurme F, et al: MST1 mutations in autosomal 146. Samuels ME, Majewski J, Alirezaie N, et al: Exome sequencing identifies mutations in
recessive primary immunodeficiency characterized by defective naive T-cell survival. the gene TTC7A in French-Canadian cases with hereditary multiple intestinal atresia.
Blood 119:3458–3468, 2012. J Med Genet 50:324–329, 2013.
115. Abdollahpour H, Appaswamy G, Kotlarz D, et al: The phenotype of human STK4 defi- 147. Chen R, Giliani S, Lanzi G, et al: Whole-exome sequencing identifies tetratricopeptide
ciency. Blood 119:3450–3457, 2012. repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal
116. de la Calle-Martin O, Hernandez M, Ordi J, et al: Familial CD8 deficiency due to a atresias. J Allergy Clin Immunol 132:656–664 e17, 2013.
mutation in the CD8 alpha gene. J Clin Invest 108:117–123, 2001. 148. Bigorgne AE, Farin HF, Lemoine R, et al: TTC7A mutations disrupt intestinal epithelial
117. Mancebo E, Moreno-Pelayo MA, Mencia A, et al: Gly111Ser mutation in CD8A gene apicobasal polarity. J Clin Invest 124:328–337, 2014.
causing CD8 immunodeficiency is found in Spanish Gypsies. Mol Immunol 45:479–484, 149. Avitzur Y, Guo C, Mastropaolo LA, et al: Mutations in tetratricopeptide repeat domain
2008. 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology
118. Jabara HH, Ohsumi T, Chou J, et al: A homozygous mucosa-associated lymphoid tissue 1 146:1028–1039, 2014.
(MALT1) mutation in a family with combined immunodeficiency. J Allergy Clin Immunol 150. Fischer RT, Friend B, Talmon GA, et al: Intestinal transplantation in children with mul-
132:151–158, 2013. tiple intestinal atresias and immunodeficiency. Pediatr Transplant 18:190–196, 2014.
119. Stepensky P, Keller B, Buchta M, et al: Deficiency of caspase recruitment domain family, 151. Cliffe ST, Bloch DB, Suryani S, et al: Clinical, molecular, and cellular immunologic find-
member 11 (CARD11), causes profound combined immunodeficiency in human sub- ings in patients with SP110-associated veno-occlusive disease with immunodeficiency
jects. J Allergy Clin Immunol 131:477–85 e1, 2013. syndrome. J Allergy Clin Immunol 130:735–742 e6, 2012.
120. Greil J, Rausch T, Giese T, et al: Whole-exome sequencing links caspase recruitment 152. Roscioli T, Cliffe ST, Bloch DB, et al: Mutations in the gene encoding the PML nuclear
domain 11 (CARD11) inactivation to severe combined immunodeficiency. J Allergy body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive
Clin Immunol 131:1376–1383 e3, 2013. disease. Nat Genet 38:620–622, 2006.
121. Pannicke U, Baumann B, Fuchs S, et al: Deficiency of innate and acquired immunity 153. Ganaiem H, Eisenstein EM, Tenenbaum A, et al: The role of hematopoietic stem cell
caused by an IKBKB mutation. N Engl J Med 369:2504–2514, 2013. transplantation in SP110 associated veno-occlusive disease with immunodeficiency
122. Courtois G, Smahi A, Reichenbach J, et al: A hypermorphic IkappaBalpha mutation is syndrome. Pediatr Allergy Immunol 24:250–256, 2013.
associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immu- 154. Kobrynski LJ, Sullivan KE: Velocardiofacial syndrome, DiGeorge syndrome: The chro-
nodeficiency. J Clin Invest 112:1108–1115, 2003. mosome 22q11.2 deletion syndromes. Lancet 370:1443–1452, 2007.
123. Picard C, Casanova JL, Puel A: Infectious diseases in patients with IRAK-4, MyD88, 155. Markert ML, Devlin BH, Alexieff MJ, et al: Review of 54 patients with complete
NEMO, or IkappaBalpha deficiency. Clin Microbiol Rev 24:490–497, 2011. DiGeorge anomaly enrolled in protocols for thymus transplantation: Outcome of 44
124. Shiow LR, Roadcap DW, Paris K, et al: The actin regulator coronin 1A is mutant in a consecutive transplants. Blood 109:4539–4547, 2007.
thymic egress-deficient mouse strain and in a patient with severe combined immuno- 156. Lingman Framme J, Borte S, von Dobeln U, et al: Retrospective analysis of TREC based
deficiency. Nat Immunol 9:1307–1315, 2008. newborn screening results and clinical phenotypes in infants with the 22q11 deletion
125. Moshous D, Martin E, Carpentier W, et al: Whole-exome sequencing identifies Coronin-1A syndrome. J Clin Immunol 34:514–519, 2014.
deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphopro- 157. Land MH, Garcia-Lloret MI, Borzy MS, et al: Long-term results of bone marrow trans-
liferation. J Allergy Clin Immunol 131:1594–1603, 2013. plantation in complete DiGeorge syndrome. J Allergy Clin Immunol 120:908–915, 2007.
126. van Montfrans JM, Hoepelman AI, Otto S, et al: CD27 deficiency is associated with 158. Jongmans MC, Admiraal RJ, van der Donk KP, et al: CHARGE syndrome: The pheno-
combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin typic spectrum of mutations in the CHD7 gene. J Med Genet 43:306–314, 2006.
Immunol 129:787–793 e6, 2012. 159. Pignata C, Fiore M, Guzzetta V, et al: Congenital Alopecia and nail dystrophy asso-
127. Martin E, Palmic N, Sanquer S, et al: CTP synthase 1 deficiency in humans reveals its ciated with severe functional T-cell immunodeficiency in two sibs. Am J Med Genet
central role in lymphocyte proliferation. Nature 510:288–292, 2014. 65:167–170, 1996.
128. de la Salle H, Zimmer J, Fricker D, et al: HLA class I deficiencies due to mutations in 160. Markert ML, Marques JG, Neven B, et al: First use of thymus transplantation therapy
subunit 1 of the peptide transporter TAP1. J Clin Invest 103:R9–R13, 1999. for FOXN1 deficiency (nude/SCID): A report of 2 cases. Blood 117:688–696, 2011.
129. de la Salle H, Hanau D, Fricker D, et al: Homozygous human TAP peptide transporter 161. Bennett CL, Christie J, Ramsdell F, et al: The immune dysregulation, polyendocrinop-
mutation in HLA class I deficiency. Science 265:237–241, 1994. athy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat
130. Yabe T, Kawamura S, Sato M, et al: A subject with a novel type I bare lymphocyte syn- Genet 27:20–21, 2001.
drome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombina- 162. Torgerson TR, Genin A, Chen C, et al: FOXP3 inhibits activation-induced NFAT2 expres-
tion. Blood 100:1496–1498, 2002. sion in T cells thereby limiting effector cytokine expression. J Immunol 183:907–915, 2009.
131. Gadola SD, Moins-Teisserenc HT, Trowsdale J, et al: TAP deficiency syndrome. Clin 163. Burroughs LM, Torgerson TR, Storb R, et al: Stable hematopoietic cell engraftment
Exp Immunol 121:173–178, 2000. after low-intensity nonmyeloablative conditioning in patients with immune dysregu-
132. Zimmer J, Andres E, Donato L, et al: Clinical and immunological aspects of HLA class lation, polyendocrinopathy, enteropathy, X-linked syndrome. J Allergy Clin Immunol
I deficiency. QJM 98:719–727, 2005. 126:1000–1005, 2010.
133. Picard C, Fischer A: Hematopoietic stem cell transplantation and other management 164. Aoki CA, Roifman CM, Lian ZX, et al: IL-2 receptor alpha deficiency and features of
strategies for MHC class II deficiency. Immunol Allergy Clin North Am 30:173–178, primary biliary cirrhosis. J Autoimmun 27:50–53, 2006.
2010. 165. Caudy AA, Reddy ST, Chatila T, et al: CD25 deficiency causes an immune dysregu-
134. Feske S, Gwack Y, Prakriya M, et al: A mutation in Orai1 causes immune deficiency by lation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10
abrogating CRAC channel function. Nature 441:179–185, 2006. expression from CD4 lymphocytes. J Allergy Clin Immunol 119:482–487, 2007.
135. Picard C, McCarl CA, Papolos A, et al: STIM1 mutation associated with a syndrome of 166. Kofoed EM, Hwa V, Little B, et al: Growth hormone insensitivity associated with a
immunodeficiency and autoimmunity. N Engl J Med 360:1971–1980, 2009. STAT5b mutation. N Engl J Med 349:1139–1147, 2003.
136. Li FY, Chaigne-Delalande B, Kanellopoulou C, et al: Second messenger role for Mg2+ 167. Nadeau K, Hwa V, Rosenfeld RG: STAT5b deficiency: An unsuspected cause of growth
revealed by human T-cell immunodeficiency. Nature 475:471–476, 2011. failure, immunodeficiency, and severe pulmonary disease. J Pediatr 158:701–708, 2011.

Kaushansky_chapter 80_p1211-1238.indd 1234 9/18/15 10:02 AM